345 related articles for article (PubMed ID: 19590166)
21. The efficacy of photodynamic therapy in treatment of recurrent squamous cell and basal cell carcinoma.
Farhadi M; Kamrava SK; Behzadi AH; Rafiezadeh P; Asghari A; Rezvan F; Maleki S
J Drugs Dermatol; 2010 Feb; 9(2):122-6. PubMed ID: 20214173
[TBL] [Abstract][Full Text] [Related]
22. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer.
Attili SK; Lesar A; McNeill A; Camacho-Lopez M; Moseley H; Ibbotson S; Samuel ID; Ferguson J
Br J Dermatol; 2009 Jul; 161(1):170-3. PubMed ID: 19302071
[TBL] [Abstract][Full Text] [Related]
23. Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): A retrospective case series and cohort study.
Kessels J; Hendriks J; Nelemans P; Mosterd K; Kelleners-Smeets N
J Am Acad Dermatol; 2016 May; 74(5):899-906. PubMed ID: 26774689
[TBL] [Abstract][Full Text] [Related]
24. Bioavailability of aminolaevulinic acid and methylaminolaevulinate in basal cell carcinomas: a perfusion study using microdialysis in vivo.
Sandberg C; Halldin CB; Ericson MB; Larkö O; Krogstad AL; Wennberg AM
Br J Dermatol; 2008 Nov; 159(5):1170-6. PubMed ID: 18717673
[TBL] [Abstract][Full Text] [Related]
25. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.
Amlashi SF; Riffaud L; Brassier G; Morandi X
Cancer; 2003 Aug; 98(3):618-24. PubMed ID: 12879481
[TBL] [Abstract][Full Text] [Related]
26. Complete resolution of a squamous cell carcinoma of the skin using intralesional 5-aminolevulinic acid photodynamic therapy intralesional PDT for SCC.
Sotiriou E; Apalla Z; Ioannides D
Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):269-71. PubMed ID: 21175857
[TBL] [Abstract][Full Text] [Related]
27. Topical methyl aminolevulinate photodynamic therapy for management of basal cell carcinomas in patients with basal cell nevus syndrome improves patient's satisfaction and reduces the need for surgical procedures.
Pauwels C; Mazereeuw-Hautier J; Basset-Seguin N; Livideanu C; Viraben R; Paul C; Meyer N
J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):861-4. PubMed ID: 21668511
[TBL] [Abstract][Full Text] [Related]
28. Combined carbon dioxide laser with photodynamic therapy for nodular and superficial basal cell carcinoma.
Shokrollahi K; Javed M; Aeuyung K; Ghattaura A; Whitaker IS; O'Leary B; James W; Murison M
Ann Plast Surg; 2014 Nov; 73(5):552-8. PubMed ID: 23407256
[TBL] [Abstract][Full Text] [Related]
29. Possibility of treating basal cell carcinomas of nevoid basal cell carcinoma syndrome with superficial x-ray therapy.
Caccialanza M; Percivalle S; Piccinno R
Dermatology; 2004; 208(1):60-3. PubMed ID: 14730239
[TBL] [Abstract][Full Text] [Related]
30. Topical photodynamic therapy of actinic keratosis in renal transplant recipients.
Piaserico S; Belloni Fortina A; Rigotti P; Rossi B; Baldan N; Alaibac M; Marchini F
Transplant Proc; 2007; 39(6):1847-50. PubMed ID: 17692630
[TBL] [Abstract][Full Text] [Related]
31. Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: A bilaterally controlled comparison study.
Maytin EV; Kaw U; Ilyas M; Mack JA; Hu B
Photodiagnosis Photodyn Ther; 2018 Jun; 22():7-13. PubMed ID: 29471147
[TBL] [Abstract][Full Text] [Related]
32. Factors affecting the recurrence rate of basal cell carcinoma.
Bøgelund FS; Philipsen PA; Gniadecki R
Acta Derm Venereol; 2007; 87(4):330-4. PubMed ID: 17598036
[TBL] [Abstract][Full Text] [Related]
33. A 10-year follow-up on the chemopreventive role of photodynamic therapy in a Gorlin syndrome patient.
Thompson A; Mattia A; Green WH; Cognetta AB
Australas J Dermatol; 2022 Nov; 63(4):e378-e379. PubMed ID: 36222440
[No Abstract] [Full Text] [Related]
34. Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome.
Chapas AM; Gilchrest BA
J Drugs Dermatol; 2006 Feb; 5(2 Suppl):3-5. PubMed ID: 16485873
[TBL] [Abstract][Full Text] [Related]
35. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage.
Soler AM; Warloe T; Berner A; Giercksky KE
Br J Dermatol; 2001 Sep; 145(3):467-71. PubMed ID: 11531838
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes following Foscan®-PDT of basal cell carcinomas.
Betz CS; Rauschning W; Stranadko EP; Riabov MV; Volgin VN; Albrecht V; Nifantiev NE; Hopper C
Lasers Surg Med; 2012 Sep; 44(7):533-40. PubMed ID: 22851213
[TBL] [Abstract][Full Text] [Related]
37. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
38. Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical fiber diffuser laser.
Madan V; Loncaster JA; Allan D; Lear JT; Sheridan L; Leach C; Allan E
J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S86-9. PubMed ID: 17052541
[TBL] [Abstract][Full Text] [Related]
39. The use of the photodynamic method in the treatment of recurrent basal cell carcinoma on the example of Gorlin-Goltz syndrome-management algorithm.
Osiecka BJ; Nockowski P; Szepietowski JC
Dermatol Ther; 2020 Nov; 33(6):e14499. PubMed ID: 33141489
[TBL] [Abstract][Full Text] [Related]
40. [Gorlin syndrome: photodynamic therapy, as a useful adjunct to surgery].
Huguier V; Wierzbicka-Hainaut E; Fray J; Guillet G; Dagrégorio G
Ann Chir Plast Esthet; 2012 Apr; 57(2):173-6. PubMed ID: 21907481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
